LFWD · Lifeward Ltd.
$5.93
-0.07 (-1.17%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company incurred a consolidated net loss of $22.3 million and, as of June 30, 2026, had an accumulated deficit in the total amount of $307.1 million. The Company's cash and cash equivalents as of June 30, 2026 totaled $9.4 million and the Company's negative operating cash flow for the six months ended June 30, 2026 was $9.7 million. The Company expects to continue to generate operating losses and negative operating cash flows in the foreseeable future and will require additional funding to support its planned operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern for at least 12 months from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$16.79M
Shares
2.83M
Volume · Oct 19
6429
Avg daily vol (3M)
5968
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.93
Open$6.16
Day$5.88–6.20
52W close$4.60–9.12
Avg vol 30d6K
Short int97K · 3.4% float · 22.7d
Short vol28%
Last earningsMay 15, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2026
call held May 15, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$21.82M
Trailing 12 months
Net income (TTM)
−$30.83M
Trailing 12 months
Revenue growth YoY
+15.7%
Year over year
Operating margin
-104.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-100.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+198.9%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
3.4%
Latest settlement · 22.7 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−16%
below
Price vs 50-day avg
−15%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
29%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−15%
trailing
6-month return
−21%
trailing
YTD return
−14%
this year
Relative strength
−29%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $7 › 200d $7 — 200d above 50d
Institutional flow
Accumulating
+13% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.41% of float · ▼ -7.9% MoM · 22.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
9 holders — mid 3-yr range
Squeeze score
55
elevated · 0–100
Fundamentals
Revenue growth
−14%
Y/Y
Gross margin
38%
expanding
EPS growth
+57%
Y/Y
Free cash flow
$-16.8M
Balance sheet
$9.3M
net cash
Quant / Vol
risk profile
Volatility
74%
annualized · 1-yr
Max drawdown
−50%
past year
ATR
6.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the Earnings Call filed Nov 14, 2025
Revenue
· full-year 2025
$24M – $26M
Guided vs delivered
· last 3 settled
Revenue
full-year 2025
guided $24M – $26M
$22.03M
Miss −11.9%
Full year revenue
full year 2024
guided $28M – $32M
$25.66M
Miss −14.5%
Revenue
first quarter of 2024
guided $5M – $5.5M
$5.28M
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−16%
Bearish
Price vs 50-day avg
−15%
Bearish
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
29%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
Death cross
50d $7 › 200d $7 — 200d above 50d
Institutional flow
Accumulating
+13% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.41% of float · ▼ -7.9% MoM · 22.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
9 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $5
Now $6 · 29%
Range high $9
vs 200-day avg -16%
vs 50-day avg -15%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| adjusted net loss non-GAAP | $4.1M | second quarter of 2026 | — |
| adjusted operating expenses non-GAAP | $6.5M | second quarter of 2026 | — |
| adjusted operating loss non-GAAP | $3.8M | second quarter of 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LFWD
this stock
Lifeward Ltd.
|
$16.79M | — | -14.1% | — | 3.4% |
|
ABT
Abbott Laboratories
|
$180.99B | -16.9% | +5.7% | 33.6 | 0.8% |
|
MDT
Medtronic plc
|
$118.67B | -3.4% | +8.4% | 22.9 | 3.1% |
|
SYK
Stryker Corp
|
$114.28B | -15.2% | +11.2% | 30.9 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.16B | -52.8% | +12.5% | 18.2 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LFWD | -4.7% | -15.3% | -20.8% | -10.2% | -14.4% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -3.2% | -14.4% | -28.5% | -10.7% | -26.8% |